Are Cystic Fibrosis Aspergillus fumigatus Isolates Different? Intermicrobial Interactions with Pseudomonas

Hasan Nazik1,2,3, Richard B Moss4, Vyshnavi Karna1

  • 1California Institute for Medical Research, 2260 Clove Dr., San Jose, CA, 95128, USA.

Mycopathologia
|November 9, 2016
PubMed

Insights

Pseudomonas aeruginosa biofilms are susceptible to Aspergillus fumigatus in cystic fibrosis (CF). However, CF-adapted Aspergillus isolates showed no difference in susceptibility to Pseudomonas aeruginosa compared to non-CF strains.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Cystic Fibrosis Research

Background:

  • Pseudomonas aeruginosa and Aspergillus fumigatus are primary pathogens in cystic fibrosis (CF) airways.
  • CF-resident Pseudomonas aeruginosa exhibits significant genetic and phenotypic adaptations.
  • Previous studies indicated altered antifungal susceptibility in Aspergillus fumigatus from CF patients.

Purpose of the Study:

  • To investigate if Aspergillus fumigatus isolates from CF patients exhibit altered susceptibility to Pseudomonas aeruginosa.
  • To compare the susceptibility of CF-adapted Aspergillus to Pseudomonas aeruginosa with non-CF Aspergillus strains.

Main Methods:

  • Comparative analysis of Pseudomonas aeruginosa susceptibility.
  • Utilized reference virulent non-CF Aspergillus and Aspergillus isolates from CF patients.
  • Evaluated biofilm susceptibility.

Main Results:

  • Pseudomonas aeruginosa biofilms demonstrated susceptibility to Aspergillus fumigatus, particularly CF phenotypes.
  • CF-derived Aspergillus isolates did not show altered susceptibility to Pseudomonas aeruginosa compared to non-CF isolates.
  • The CF environment does not appear to alter Aspergillus' susceptibility to Pseudomonas.

Conclusions:

  • While Pseudomonas aeruginosa biofilms are susceptible to Aspergillus, the CF environment does not significantly alter Aspergillus' susceptibility to Pseudomonas.
  • CF-associated Aspergillus isolates maintain similar susceptibility profiles to Pseudomonas aeruginosa as non-CF isolates.
  • Further research may explore other interactions between CF pathogens.

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
994
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
667
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
824
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
601